Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia)
William R. Hazzard, … , Daniel Porte Jr., Edwin L. Bierman
William R. Hazzard, … , Daniel Porte Jr., Edwin L. Bierman
Published October 1, 1970
Citation Information: J Clin Invest. 1970;49(10):1853-1858. https://doi.org/10.1172/JCI106403.
View: Text | PDF
Research Article

Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia)

  • Text
  • PDF
Abstract

Chylomicron (primary particles) were detected by polyvinylpyrollidone (PVP) flocculation in plasma collected after an overnight fast from eight hyperlipemic subjects with broad-β disease (type III hyperlipoproteinemia). The composition of these chylomicrons was abnormal: relatively poor in triglyceride and rich in cholesterol, giving rise to a triglyceride/cholesterol ratio of < 3.0 in all cases, uniformly below the ratio in chylomicrons from eight fasting subjects with mixed lipemia. By contrast, at the peak of alimentary lipemia following an oral fat load (2 g/kg), chylomicrons from broad-β subjects had normal, triglyceride-rich composition (triglyceride/cholesterol = 14.0) and resembled chylomicrons from subjects with mixed lipemia, endogenous lipemia, and familial hypercholesterolemia after similar fat loads. As the alimentary lipemia cleared, chylomicrons remaining in broad-β subjects 14-24 hr after the fat load were again rich in cholesterol. However, a similar degree of cholesterol enrichment was observed in chylomicrons from the subjects with familial hypercholesterolemia, while only a minor increase in cholesterol was recorded in chylomicrons from subjects with mixed or endogenous lipemia. Parallel studies of changes in chylomicron composition during in vitro incubation of whole plasma and of Sf > 400 with Sf < 400 lipoproteins from subjects with the different forms of hyperlipoproteinemia revealed equal cholesterol enrichment of chylomicrons from a subject with mixed lipemia and from a subject with broad-β disease in media of equivalent cholesterol content. These experiments suggested neither excessive avidity of chylomicrons for cholesterol uptake nor excessive influence of Sf < 400 lipoproteins upon chylomicron composition in broad-β disease.

Authors

William R. Hazzard, Daniel Porte Jr., Edwin L. Bierman

×

Total citations by year

Year: 2020 2016 1988 1987 1985 1983 1982 1981 1980 1979 1978 1977 1976 1975 1973 1972 1962 Total
Citations: 2 1 1 1 1 1 4 1 1 4 2 2 4 8 5 3 1 42
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (42)

Title and authors Publication Year
Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
A Chait, HN Ginsberg, T Vaisar, JW Heinecke, IJ Goldberg, KE Bornfeldt
Diabetes 2020
The clinical and laboratory investigation of dysbetalipoproteinemia
CS Boot, A Luvai, RD Neely
Critical Reviews in Clinical Laboratory Sciences 2020
Type III Hyperlipoproteinemia: Still Worth Considering?
CB Blum
Progress in Cardiovascular Diseases 2016
Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery disease
PT Kuo, AC Wilson, JB Kostis, AB Moreyra, HT Dodge
American Heart Journal 1988
Hepatic Chylomicron Remnant (Apolipoprotein E) Receptors: Their Physiologic and Clinical Importance
CH Florén, Å Nilsson
Scandinavian Journal of Gastroenterology 1987
Xanthomas and hyperlipidemias
F Parker
Journal of the American Academy of Dermatology 1985
Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia
JP Kane, GC Chen, RL Hamilton, DA Hardman, MJ Malloy, RJ Havel
Arteriosclerosis (Dallas, Tex.) 1983
In vitro reciprocal exchange of apoproteins and nonpolar lipids between human high density lipoproteins and an artificial triglyceride-phospholipid emulsion (Intralipid)
RB Weinberg, AM Scanu
Atherosclerosis 1982
Lipoprotein Kinetics and Modeling
SM Grundy, GL Vega
Lipoprotein Kinetics and Modeling 1982
Familial Dysbetalipoproteinemia: New Aspects of Pathogenesis and Diagnosis
RJ Havel
Medical Clinics of North America 1982
Chylomicronemia Syndrome: Interaction of Genetic and Acquired Hypertriglyceridemia
JD Brunzell, EL Bierman
Medical Clinics of North America 1982
Long-term treatment of type III hyperlipoproteinemia with clofibrate
PM Stuyt, PN Demacker, AV Laar
Atherosclerosis 1981
Atherosclerosis V
AM Gotto, LC Smith, B Allen
1980
Normocholesterolemic dysbetalipoproteinemia with xanthomatosis
JJ Abrams, SM Grundy, JP Kane, CM Chang
Metabolism 1979
Type III hyperlipoproteinemia
JM Falko, JL Witztum, G Schonfeld, SW Weidman, JB Kolar
The American Journal of Medicine 1979
Effects of estrogen therapy on apolipoprotein E in type III hyperlipoproteinemia
JM Falko, G Schonfeld, JL Witztum, J Kolar, SW Weidman
Metabolism 1979
Atherogenesis: a postprandial phenomenon
DB Zilversmit
Circulation 1979
Metabolism of cholesterol-rich chylomicroms. Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart
CJ Fielding
Journal of Clinical Investigation 1978
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: Comparison with endogenous hypertriglyceridemia
A Chait, WR Hazzard, JJ Albers, RP Kushwaha, JD Brunzell
Metabolism 1978
Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia
JR Patsch, D Yeshurun, RL Jackson, AM Gotto
The American Journal of Medicine 1977
The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: Comparison with normal subjects
P Stromberg, D Ballantyne, FC Ballantyne, JL Third, DK Bedford
Clinica Chimica Acta 1977
Chylomicron metabolism in rabbits fed diets with or without added cholesterol
TG Redgrave, KB Dunne, DC Roberts, CE West
Atherosclerosis 1976
Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (type III hyperlipoproteinemia)
WR Hazzard, EL Bierman
Metabolism 1976
Low Density Lipoproteins
CE Day, RS Levy
1976
Fettstoffwechsel
G Assmann, J Augustin, E Baraona, HU Benz, W Brech, WV Brown, RJ Desnick, WR Fallat, S Ford, D Fredrickson, CJ Glueck, H Greten, K Harzer, P Herbert, GM Kostner, W Krivit, RI Levy, CS Lieber, M Liersch, G Middelhoff, GL Mills, NB Myant, RF ODea, J Papenberg, H Pilz, HM Rauen, S Sailer, G Schettler, G Schlierf, H Schriewer, D Seidel, J Slack, E Stange, O Stein, Y Stein, D Steinberg, A Weizel, H Wieland
1976
Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat
OD Mjos, O Faergeman, RL Hamilton, RJ Havel
Journal of Clinical Investigation 1975
Quantitative and qualitative serum lipoprotein analysis
LA Carlson, M Ericsson
Atherosclerosis 1975
Lipoprotein of the Density 1. 006–1. 020 in the Plasma of Patients with Type III Hyperlipoproteinaemia in the Postabsorptive State
JR Patsch, S Sailer, H Braunsteiner
European Journal of Clinical Investigation 1975
Broad-β disease versus endogenous hypertriglyceridemia: Levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia
WR Hazzard, EL Bierman
Metabolism 1975
Autoimmune hyperlipidemia in a patient
LA Lewis, VG deWolfe, A Butkus, IH Page
The American Journal of Medicine 1975
A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemia
MA Mishkel, DJ Nazir, S Crowther
Clinica Chimica Acta 1975
Hypolipidemic Agents
D Kritchevsky
1975
Lipids, Lipoproteins, and Drugs
D Kritchevsky, R Paoletti, WL Holmes
1975
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
WR Hazzard, JL Goldstein, MG Schrott, AG Motulsky, EL Bierman
Journal of Clinical Investigation 1973
Abnormal Lipoprotein Lipase in Familial Exogenous Hypertriglyceridemia
PH Schreibman, DL Arons, CD Saudek, RA Arky
Journal of Clinical Investigation 1973
Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins
RJ Havel, JP Kane
Proceedings of the National Academy of Sciences 1973
Type III hyperlipoproteinaemia
S Eisenberg
Clinics in Endocrinology and Metabolism 1973
A Proposal Linking Atherogenesis to the Interaction of Endothelial Lipoprotein Lipase with Triglyceride-Rich Lipoproteins
DB Zilversmit
Circulation research 1973
Metabolic relationships among the plasma lipoproteins Reciprocal changes in the concentrations of very low and low density lipoproteins in man
DE Wilson, RS Lees
Journal of Clinical Investigation 1972
Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (Type III hyperlipoproteinemia)
WR Hazzard, D Porte, EL Bierman
Metabolism 1972
Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans
T Sata, RJ Havel, AL Jones
Journal of lipid research 1972
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel
1962

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts